Journal of Preclinical Therapeutics

ISSN: Application in progress

Journal of Preclinical Therapeutics

A peer-reviewed, open-access journal publishing original preclinical research across target discovery, drug discovery, pharmacokinetics, toxicology, immunopharmacology, formulation and drug delivery, and translational efficacy modeling.

Open Access Peer-Reviewed Double-Blind Review Biannual CC BY 4.0

CALL FOR PAPERS

Submissions are now open for Volume 1, Issue 1 — help shape our inaugural issue.

Submit your manuscript →

Now Forming

The Journal of Preclinical Therapeutics is a new, peer-reviewed open-access journal currently accepting submissions for its inaugural issue.

We're building JPT the way an indexed journal is expected to run from day one: a real double-blind peer review process, a defined editorial policy, and full transparency about where we are in our launch. No issue has been published yet — this page will list our first accepted articles as they clear peer review.

What We're Looking For

Original research in pharmacokinetics, toxicology, immunopharmacology, and translational efficacy modeling.

See the Aims & Scope and Ethics & Policies pages for full detail, and the Guide for Authors for submission requirements. We particularly welcome studies using reduced-animal and alternative methodologies.

Read the submission guidelines →

Aims & Scope

The Journal of Preclinical Therapeutics publishes original, peer-reviewed research at the preclinical stage of drug development — spanning pharmacokinetics, toxicology, immunopharmacology, formulation and drug delivery, computational drug design, phytoconstituent pharmacology, and translational efficacy modeling.

Read the full Aims & Scope, article types, and review policy →

Submit to our inaugural issue

Double-blind peer review · Immediate open access · No embargo on acceptance

Start a submission